Eminox

Minoxidil.

Each ml of topical solution contains: Minoxidil 50mg.

Topically, Minoxidil is a vasodilator and increasing blood supply to hair follicle to stimulate hair growth.

Treatment of Androgenetica baldness (Alopecia adrigenetica) in men, application for women is not recommended, it may cause hair growth on the face.

Use as directed. Apply or spray total dose of 1 ml twice daily to the affected area. This dose should be used regardless of the size of the affected area. In order to spread it evenly, spread Eminox with fingertips to cover all the bald area, beginning at the center of the affected area. Repeat for a total 6 times to apply a dose of 1 ml solution. The total daily dose should not exceed 2 ml, unless by doctor's recommendation. Apply Eminox on dry scalp. Wash hands thoroughly immediately after applying Eminox. Regular application will have hair growth effect in 4 months or more. Onset and degree may be variable among patients.
The product can be used within 35 days after opened.

Patients with a history of hypersensitivity to Minoxidil.
Patients with hypertension, including those under treatment with antihypertensive agents.
Patients with scalp abnormality disorder (including psoriasis and sunburn).
Patients with shaved scalp.
Patients with head-bandage or other medical instrument.

The physician should determine that the patient has a normal, healthy scalp.
Do not use hair dryer as it may reduce Eminox effectively.
Based on safety and effectivity Eminox is only given for patient age 18-65 years.
Patient should be monitored 1 month after starting therapy and at least 6 months hereafter.
Do not swallow. Accidental ingestion may produce systemic effect related to vasodilating action of Minoxidil. Signs and symptoms would most likely be cardiovascular effects associated with fluid retention, hypotension, and tachycardia. Fluid retention can be managed with appropriate diuretics treatment. Tachycardia can be controlled by administration of beta adrenergic blocking agent. Hypotension should be treated by iv administration of normal saline.
Cessation of Eminox treatment may lead to the loss of new hair growth.
Discontinue Eminox application if there is undesirable or systemic effect.
Eminox should not be used concomitantly with other topical dermatologic preparation.
Eminox should not be used in patients with coronary heart disease, arrhythmia, heart failure or valvular heart disease. If any other cardiovascular disease is present, it becomes a matter of medical judgement whether or not a patient should be permitted to use Eminox.

Local irritation such as dry skin, redness, itching, hypertrichosis (hair overgrowth) in not treated area, and skin burn sensation may occur. Rarely reported adverse reactions include allergic reaction such as dizziness, eye irritation, ear infection (otilitis external), and blurred vision.

There are currently no known drug interactions associated with the use of Minoxidil. Although it has not been clinically demonstrated there exists the possibility of potentiating orthostatic hypotension in patients concurrently taking Guanethidine.

Store below 30°C, tightly closed, and protect from light.

Other Dermatologicals

D11AX01 - minoxidil ; Belongs to the class of other dermatologicals.

G